This stuff, mobocertinib, it’s a kind of inhibitor for that EGFR thing. It’s mainly used for treating NSCLC in folks with these specific EGFR exon 20 mutations. So, it works by going after the EGFR to stop the cancer cells from growing.
You can get this in 40 mg pill form. They usually suggest taking 160 mg a day, and you can take it with or without something to eat. Each bottle holds 90 pills.
The main ingredient is aimed at those specific mutations in the EGFR gene that cause cancer cells to grow in NSCLC patients. It’s a targeted therapy, which means it tries to minimize side effects by only hitting the cancer cells with that mutation.
